Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6AOC

Crystal Structure of an N-Hydroxythienopyrimidine-2,4-dione RNase H Active Site Inhibitor with Multiple Binding Modes to HIV Reverse Transcriptase

Summary for 6AOC
Entry DOI10.2210/pdb6aoc/pdb
DescriptorReverse transcriptase/ribonuclease H, p51 RT, MANGANESE (II) ION, ... (7 entities in total)
Functional Keywordshiv-1, transferase - transferase inhibitor complex, transferase / transferase inhibitor
Biological sourceHuman immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1)
More
Total number of polymer chains4
Total formula weight234444.14
Authors
Kirby, K.A.,Sarafianos, S.G. (deposition date: 2017-08-15, release date: 2018-08-08, Last modification date: 2023-10-04)
Primary citationKankanala, J.,Kirby, K.A.,Huber, A.D.,Casey, M.C.,Wilson, D.J.,Sarafianos, S.G.,Wang, Z.
Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H.
Eur J Med Chem, 141:149-161, 2017
Cited by
PubMed Abstract: Human immunodeficiency virus (HIV) reverse transcriptase (RT) associated ribonuclease H (RNase H) is the only HIV enzymatic function not targeted by current antiviral drugs. Although various chemotypes have been reported to inhibit HIV RNase H, few have shown significant antiviral activities. We report herein the design, synthesis and biological evaluation of a novel N-hydroxy thienopyrimidine-2,3-dione chemotype (11) which potently and selectively inhibited RNase H with considerable potency against HIV-1 in cell culture. Current structure-activity-relationship (SAR) identified analogue 11d as a nanomolar inhibitor of RNase H (IC = 0.04 μM) with decent antiviral potency (EC = 7.4 μM) and no cytotoxicity (CC > 100 μM). In extended biochemical assays compound 11d did not inhibit RT polymerase (pol) while inhibiting integrase strand transfer (INST) with 53 fold lower potency (IC = 2.1 μM) than RNase H inhibition. Crystallographic and molecular modeling studies confirmed the RNase H active site binding mode.
PubMed: 29031062
DOI: 10.1016/j.ejmech.2017.09.054
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

237423

数据于2025-06-11公开中

PDB statisticsPDBj update infoContact PDBjnumon